This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5lyh
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='5lyh' size='340' side='right' caption='[[5lyh]], [[Resolution|resolution]] 2.17Å' scene=''> | <StructureSection load='5lyh' size='340' side='right' caption='[[5lyh]], [[Resolution|resolution]] 2.17Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5lyh]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5LYH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5LYH FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5lyh]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5LYH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5LYH FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7B8:3-[2-[4-[2-[[4-[(3-AMINOCARBONYLPHENYL)AMINO]-4-OXIDANYLIDENE-BUTANOYL]AMINO]ETHYL]-1,2,3-TRIAZOL-1-YL]ETHYLSULFAMOYL]BENZOIC+ACID'>7B8</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7B8:3-[2-[4-[2-[[4-[(3-AMINOCARBONYLPHENYL)AMINO]-4-OXIDANYLIDENE-BUTANOYL]AMINO]ETHYL]-1,2,3-TRIAZOL-1-YL]ETHYLSULFAMOYL]BENZOIC+ACID'>7B8</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5lxp|5lxp]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5lxp|5lxp]]</td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PARP14, BAL2, KIAA1268 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/NAD(+)_ADP-ribosyltransferase NAD(+) ADP-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.30 2.4.2.30] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/NAD(+)_ADP-ribosyltransferase NAD(+) ADP-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.30 2.4.2.30] </span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5lyh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5lyh OCA], [http://pdbe.org/5lyh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5lyh RCSB], [http://www.ebi.ac.uk/pdbsum/5lyh PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5lyh ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5lyh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5lyh OCA], [http://pdbe.org/5lyh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5lyh RCSB], [http://www.ebi.ac.uk/pdbsum/5lyh PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5lyh ProSAT]</span></td></tr> | ||
| Line 24: | Line 25: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
[[Category: Karlberg, T]] | [[Category: Karlberg, T]] | ||
[[Category: Schuler, H]] | [[Category: Schuler, H]] | ||
Revision as of 20:39, 24 January 2018
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H10
| |||||||||||
